⌘K

Home/Filings/4/0000950170-24-081603

4//SEC Filing

Amin Dipti 4

Accession 0000950170-24-081603

CIK 0000876343other

View on SEC.gov Company Profile

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 5:00 PM ET

Size

5.3 KB

Accession

0000950170-24-081603

Insider Transaction Report

Form 4

Period: 2024-07-01

Lineage Cell Therapeutics, Inc.LCTX

Director

Transactions

Award
Stock Option (Right to Buy)
2024-07-01+75,000→ 75,000 total
Exercise: $0.95Exp: 2034-07-01→ Common Shares (75,000 underlying)

Footnotes (1)

[F1]Will vest and become exercisable on July 1, 2025, subject to the reporting person's continuous service with the issuer.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Lineage Cell Therapeutics, Inc.

CIK 0000876343

Entity typeother

Related Parties

1

filerCIK 0001856708

Filing Metadata

Form type: 4
Filed: Jul 2, 8:00 PM ET
Accepted: Jul 3, 5:00 PM ET
Size: 5.3 KB

View on SEC.gov